Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike L Pahl

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Blood|November 25, 2021
Sentinel mutations: the roses in the vineyardHeike L Pahl
Hematology (Amsterdam, Netherlands)|August 13, 2003
Molecular markers in myeloproliferative disorders: from classification to prognosis?Heike L Pahl
Acta Haematologica|October 10, 2002
Polycythaemia vera: will new markers help us answer old questions?Heike L Pahl
Blood|February 7, 2012
A JAK-in-the-cell cycleHeike L Pahl
Blood|April 5, 2014
Many roads lead to MPNHeike L Pahl
Current Hematology Reports|August 7, 2003
PRV-1 mRNA expression and other molecular markers in polycythemia rubra veraHeike L Pahl
Expert Review of Molecular Diagnostics|July 1, 2004
Diagnostic approaches to polycythemia vera in 2004Heike L Pahl
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Current evaluation of the clinical, diagnostic, and therapeutic usefulness of prv-1 and c-mpl markers in polycythemia vera and essential thrombocythemiaHeike L Pahl
Stem Cells Translational Medicine|January 24, 2013
Elevated nuclear factor erythroid-2 levels promote epo-independent erythroid maturation and recapitulate the hematopoietic stem cell and common myeloid progenitor expansion observed in polycythemia vera patientsRuzhica Bogeska, Heike L Pahl
Pathologie-Biologie|June 26, 2004
Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disordersSteffen Klippel, Heike L Pahl
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Blood|November 25, 2021
Sentinel mutations: the roses in the vineyardHeike L Pahl
Hematology (Amsterdam, Netherlands)|August 13, 2003
Molecular markers in myeloproliferative disorders: from classification to prognosis?Heike L Pahl
Acta Haematologica|October 10, 2002
Polycythaemia vera: will new markers help us answer old questions?Heike L Pahl
Blood|February 7, 2012
A JAK-in-the-cell cycleHeike L Pahl
Blood|April 5, 2014
Many roads lead to MPNHeike L Pahl
Current Hematology Reports|August 7, 2003
PRV-1 mRNA expression and other molecular markers in polycythemia rubra veraHeike L Pahl
Expert Review of Molecular Diagnostics|July 1, 2004
Diagnostic approaches to polycythemia vera in 2004Heike L Pahl
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Current evaluation of the clinical, diagnostic, and therapeutic usefulness of prv-1 and c-mpl markers in polycythemia vera and essential thrombocythemiaHeike L Pahl
Stem Cells Translational Medicine|January 24, 2013
Elevated nuclear factor erythroid-2 levels promote epo-independent erythroid maturation and recapitulate the hematopoietic stem cell and common myeloid progenitor expansion observed in polycythemia vera patientsRuzhica Bogeska, Heike L Pahl
Pathologie-Biologie|June 26, 2004
Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disordersSteffen Klippel, Heike L Pahl
Pageof 10